Showing results (941-950 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|September 1, 2023
Relationship between baseline electrocardiographic measurements and outcomes in patients with high-risk heart failure: Insights from the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trialHaran Yogasundaram, Yinggan Zheng, Eric Ly, et al.
European Journal of Heart Failure|August 25, 2023
Baseline characteristics of patients enrolled in the EMPACT-MI trialJosephine Harrington, Jacob A Udell, W Schuyler Jones, et al.
European Journal of Heart Failure|August 26, 2023
Sex differences in long-term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines-Heart Failure registryNeil Keshvani, Sonia Shah, Iyanuoluwa Ayodele, et al.
European Journal of Heart Failure|August 27, 2023
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVERJawad H Butt, Henri Lu, Toru Kondo, et al.
European Journal of Heart Failure|June 27, 2023
Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term RegistryMarianna Adamo, Ovidiu Chioncel, Lina Benson, et al.
European Journal of Heart Failure|June 27, 2023
Heart failure diagnosis in the general community - Who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Kieran F Docherty, Carolyn S P Lam, Amina Rakisheva, et al.
European Journal of Heart Failure|June 6, 2023
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trialMichael Böhm, Javed Butler, Marcin Krawczyk, et al.
European Journal of Heart Failure|June 7, 2023
Trajectories of renal biomarkers and new-onset heart failure in the general population: Findings from the PREVEND studyRyoto Sakaniwa, Jasper Tromp, Koen W Streng, et al.
European Journal of Heart Failure|September 29, 2023
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fractionShingo Matsumoto, Toru Kondo, Mingming Yang, et al.
European Journal of Heart Failure|September 13, 2023
Supervised exercise training in patients with advanced heart failure and left ventricular assist device: A multicentre randomized controlled trial (Ex-VAD trial)Anna Feuerstein, Felix Schoenrath, Evgeny Belyavskiy, et al.
Pageof 398